MedPath

BIRENDRA KUMAR SAH

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Neoadjuvant Chemotherapy Plus Surgery Versus Surgery First For Elderly Gastric Cancer Patients

Phase 2
Not yet recruiting
Conditions
Chemotherapy Effect
Surgery
Gastric Cancer
Elderly Patients
Interventions
Drug: Chemotherapy
Procedure: Curative gastrectomy
First Posted Date
2020-12-21
Last Posted Date
2020-12-21
Lead Sponsor
BIRENDRA KUMAR SAH
Target Recruit Count
232
Registration Number
NCT04677673

Early Detection of Postoperative Anastomotic Leak by CT

Completed
Conditions
Anastomotic Leak
First Posted Date
2018-08-15
Last Posted Date
2020-05-21
Lead Sponsor
BIRENDRA KUMAR SAH
Target Recruit Count
110
Registration Number
NCT03632395
Locations
🇨🇳

Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.